19 June 2013
Keywords: fda, approves, abbott, humira, jia, health, care
Article | 03 March 2008
US health care major Abbott Laboratories has received Food and Drug
Administration approval to market Humira (adalimumab) as a treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 March 2008
18 June 2013
© 2013 thepharmaletter.com